Looking to participate in a clinical trial in your area?

Published
July 8, 2026

Site Staff Do Not Need More Recruitment Technology. They Need Less Burden

In clinical research, enrollment challenges are often discussed as a recruitment problem. More outreach is launched, additional campaigns are activated, new recruitment vendors are engaged, and new technologies are introduced to improve performance. Yet despite substantial investment across the industry, enrollment remains one of the most persistent challenges in clinical trial execution.

The reason may be simpler than many organizations are willing to acknowledge. Patient recruitment does not fail because sites lack technology. Instead, sites often struggle because the operational burden created by recruitment continues to grow, while the capacity of personnel responsible for managing that burden remains the same.

OMNI CRS recently surveyed clinical research professionals to better understand where recruitment challenges are creating the greatest operational strain. The responses reveal a consistent pattern: enrollment outcomes are heavily influenced by the increasing time burden placed on site personnel throughout the recruitment process. 

When asked which parts of the recruitment process feel heaviest operationally today, 53% said managing and qualifying patient leads, while 44% cited identifying eligible patients. These findings underscore the dual nature of today’s recruitment struggle: while finding eligible patients in a competitive landscape is inherently difficult for sites, they are simultaneously overwhelmed by the time burden of manually qualifying generic leads.

In other words, many sites are struggling– and not because nobody is responding to outreach. They are struggling because the work required to filter those responses into qualified participants has become increasingly labor intensive for staff who are already doing too much.

Across the industry, recruitment conversations often focus on volume: more impressions, more clicks, more leads, and more inquiries. And as protocols become more complex and eligibility criteria become increasingly specific, sites must screen larger numbers of potential participants to achieve enrollment goals. But for site personnel, recruitment is not measured by the number of names entering a database. It’s measured by the amount of work required to transform those names into randomized participants, and that work has expanded considerably.

One survey respondent summarized the challenge succinctly:

“We have to prescreen/screen more and more patients to find one randomization.”

Every additional screening conversation requires staff time, and every ineligible patient still requires documentation. Every missed appointment requires follow-ups, and every timeline delay creates new communication requirements among sites, sponsors, CROs, and recruitment vendors.

These activities may appear small individually, but collectively they create substantial operational pressure. The burden becomes even more visible when enrollment falls behind projections.

When survey participants were asked who absorbs the most additional work when recruitment underperforms, the response was overwhelming: 81% indicated that site staff, typically clinical research coordinators, absorb the majority of the added workload. Only 19% identified CRO operations teams.

The survey responses paint a grim picture of how this dynamic unfolds in practice. One respondent described the cascading pressure that emerges when enrollment slows: “When enrollment starts to fall behind, pressure is applied at all levels. Investors pressure the sponsor > CRO > external partners > sites, but ultimately the constant contact and request for updates falls to the site staff and coordinators.”

The survey results illustrate a problematic cascading effect when enrollment milestones are missed. As projects fall behind, a clear hierarchy of pressure emerges: investors leverage sponsors, who in turn press CROs, ultimately placing the burden of constant reporting and status updates squarely on site coordinators. This operational oversight frequently creates a reactive environment where management teams, removed from the day-to-day work, intensify their demands, such as requesting frequent communication from CRAs or pressuring sites for higher screening numbers, rather than finding solutions to the underlying recruitment challenges.

This dynamic reveals a significant disconnect in the clinical trial industry, where the immense pressure to perform is disproportionately shouldered by site staff. As one respondent noted, the responsibility for enrollment success often falls on those least equipped to mitigate the challenges, as those detached from the frontline work question why goals are not met. This creates an industry reality where the complexity of site operations is frequently underestimated, exposing a critical gap in many existing enrollment models that fail to account for the actual human and administrative bandwidth required at the site level.

When recruitment struggles, additional work rarely disappears, but instead accumulates through increased reporting, status meetings, and screening efforts. Unfortunately, these reactive activities do not necessarily improve the quality of incoming patient referrals. In fact, they can create a counterproductive cycle. The more time coordinators spend managing recruitment administration, the less time they have available for study oversight, retention activities, and patient care. Recruitment then becomes both the problem and the distraction from solving it.

This helps explain another finding from the OMNI CRS survey. When asked which statement best reflected their current recruitment experience, 64% reported that recruitment performance varies widely by study. Another 36% stated that they have already invested significantly in recruitment tech but continue to face enrollment challenges or find solutions that truly scale. These responses suggest that recruitment performance is not simply a function of investment level. If it were, increasing resources would produce more predictable outcomes.

Instead, recruitment performance often depends on how efficiently patients move through the enrollment pathway and how much friction exists between initial interest and site engagement. The challenge is not necessarily attracting more patients, it is helping sites focus their efforts on patients who are more likely to qualify, engage, and remain active in the enrollment process.

Several survey respondents highlighted the need for a fundamentally different approach.

One respondent noted, “We recently created an internal patient recruitment team to reduce site burden. Unfortunately it is common practice that CROs and sponsors just apply more pressure instead of solving issues together,” while another simply stated, “Bigger ideas and more direction needed. Next level.”

The common theme is not a demand for more recruitment technology. If anything, many sites are already managing an expanding collection of platforms, dashboards, and reporting requirements. The challenge is that these tools often redistribute work rather than eliminate it, creating additional processes that site staff must navigate alongside their existing responsibilities. This distinction is increasingly important as technology adoption continues across the clinical research industry.

Reducing burden requires a different philosophy. Rather than asking sites to adapt to new technology, recruitment technology should adapt to site operations. This is where enrollment support becomes more impactful than lead generation alone. Patient qualification, lead filtering, automated engagement, and workflow integration can significantly reduce the administrative workload associated with recruitment while improving the quality and timeliness of patient referrals. 

OMNI CRS was designed around this principle. Rather than delivering raw lead volume and shifting qualification responsibilities entirely to overburdened sites, OMNI CRS applies protocol-specific screening, patient nurturing, and engagement workflows that prime the patient before they reach the site’s doors.

OMNI CRS actively engages during prescreening with educational touchpoints delivered through texts and emails to help patients better understand study participation, informed consent processes, and what to expect throughout their enrollment journey. This engagement occurs between initial inquiry and site contact, so site staff only spend time with participants who are ready and able to consent.

Importantly, OMNI’s processes operate within existing site workflows. Through integrations with leading CTMS environments and customized implementation support, patient information remains where sites already manage their operations.

The objective behind OMNI’s recruitment performance engine is not to create another system for sites to manage, but to remove work from the system they already have. Enrollment performance cannot be separated from operational design. As studies become more complex and staffing pressures continue across the industry, recruitment success will increasingly depend on protecting the people responsible for enrolling them. This distinction may ultimately be one of the most important factors influencing future patient enrollment outcomes.

The organizations that improve enrollment outcomes in the years ahead may not be those that deploy the most recruitment technology. They may be the ones that most effectively reduce the burden that technology often creates.

The OMNI CRS survey results make one conclusion undeniable: site teams do not need additional dashboards or recruitment processes layered onto their daily responsibilities. They need fewer unqualified referrals, fewer repetitive screening activities, and fewer administrative tasks standing between patient interest and enrollment. 

By combining protocol-specific targeting, prescreening, patient education, and automated engagement before patients ever reach the site, OMNI CRS helps reduce the operational burden that recruitment often creates. Improving enrollment performance is not simply about generating more leads. It’s about delivering patients who are informed, engaged, and ready to take the next step, allowing site staff to focus their time where it creates the greatest value: conducting studies and caring for participants.

About OMNI CRS

OMNI CRS is a patient recruitment partner serving clinical trial sites, sponsors, and research organizations through targeted, data-informed patient outreach. Combining protocol-specific targeting, lead qualification, patient engagement, and integrated workflow support, OMNI CRS helps research organizations improve enrollment efficiency while reducing operational burden on site teams.

Built to align with existing site operations, OMNI CRS focuses on delivering qualified patient opportunities, minimizing unnecessary screening effort, and supporting more predictable recruitment performance across a broad range of therapeutic areas.

The Affiliati Network, the leading performance marketing network for affiliate marketers and advertisers, announced today an overhaul and refresh of their brand that represents their spirit of excellence and better.

Accelerate Your Clinical Trial Recruitment

Sponsors, CROs, sites, and recruitment partners trust OMNI CRS to accelerate clinical trial enrollment. Connect with our team to see how we can support your study.